COVID-19公共卫生危机对腹主动脉瘤破裂外科治疗的影响
基于血管质量倡议(VQI)数据库,纳入2019年1月1日至2022年8月31日期间接受干预的破裂腹主动脉瘤病例2145例,分为COVID前(745例)与COVID期间(1400例)队列。COVID期间患者总体死亡率与COVID前无显著差异,COVID阳性患者虽单因素分析死亡率较高(31.4% vs 24.9%),但合并症校正后差异消失;COVID期间破裂修复病例数在2020年4月骤降至4例,至2020年9月恢复至COVID前水平。
要点
- COVID期间破裂腹主动脉瘤修复病例数在2020年4月降至4例,2020年9月恢复至COVID前水平。
- COVID阳性患者从外院转入比例较低,且到达手术室延迟(症状开始至切口43.3小时 vs COVID期间总体24.4小时)。
- COVID阳性患者死亡率单因素分析为31.4% vs COVID期间总体24.9%,合并症校正后差异消失。
核心结论
- 尽管COVID-19疫情造成医疗系统障碍,COVID期间破裂腹主动脉瘤患者无论COVID状态如何均未增加死亡风险,且与COVID前患者基本可比。
研究设计与样本
- 回顾性队列研究,查询血管质量倡议(VQI)数据库中2019年1月1日至2022年8月31日所有接受干预的破裂腹主动脉瘤病例。
- 患者分为COVID前队列(2019年1月1日至2019年12月31日)和COVID队列(2020年4月1日至2022年8月31日),COVID队列再分为COVID未知、COVID阴性和COVID阳性亚组;2020年1月1日至3月31日因COVID状态不确定被排除。
- 共收集2145例破裂腹主动脉瘤病例(COVID前745例,COVID期间1400例)。
主要发现
- 2020年4月仅记录4例破裂修复病例,而COVID前平均每月62.1例;至2020年9月病例数恢复至COVID前水平。
- COVID阳性患者较少从外院转入,且到达手术室延迟(症状开始至切口时间:COVID阳性患者43.3小时 vs COVID期间总体24.4小时)。
- 单因素分析中COVID阳性患者破裂腹主动脉瘤死亡率高于COVID期间总体死亡率(31.4% vs 24.9%),但合并症校正后该死亡率差异消失。
- COVID阳性患者更可能合并未治疗的慢性阻塞性肺疾病、需要术后通气和血管升压药支持、以及因急性腿缺血行截肢而非保肢。
- COVID前与COVID队列在性别、种族、年龄、吸烟、心脏病史、围手术期事件、透析或术前肌酐、既往动脉瘤修复、开放 vs 腔内修复选择、最大腹主动脉瘤直径或术后住院时间方面均无统计学显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 epidemic introduced significant systems- and disease-based uncertainty into Abdominal Aortic Aneurysm (AAA) rupture management. The goal of this work was to evaluate whether short-term AAA rupture outcomes during COVID-19 were comparable to pre-COVID era outcomes and to explore the impact of COVID status and COVID era health-care systems restrictions on AAA rupture outcomes. METHODS: The Vascular Quality Initiative database was queried for all ruptured AAAs that underwent intervention from January 1, 2019, to August 31, 2022. Patients were divided into pre-COVID (1/1/19-12/31/19) and COVID (4/1/20-8/31/22) cohorts. The COVID group was subdivided into COVID unknown, COVID-, and COVID + subgroups. 1/1-3/31/2020 was excluded due to COVID status uncertainty during this time. For the univariate analysis, categorical variables were compared using the Χ2 test; continuous variables were compared either using a two-tailed heteroscedastic Student's t-test or analysis of variance. The multivariate analysis was performed using logistic regression module of IBM SPSS Statistics (V25). RESULTS: 2,145 cases (pre-COVID: 745; COVID: 1,400) of AAA rupture were collected. Only 4 documented cases of rupture repair occurred during April 2020 compared to pre-COVID average of 62.1 cases/month. Rupture case numbers recovered to pre-COVID volumes by September 2020. COVID + patients were less likely to be transferred from outside institutions and experienced delays to operating room arrival (time of symptom start to incision of 43.3 hours for COVID + vs. 24.4 hours for all COVID era). Although the COVID + mortality rate for AAA rupture was higher the overall COVID era mortality rate (31.4% vs. 24.9%) in the univariate analysis, this mortality difference went away with comorbid adjustments. However, COVID + patients were more likely to have untreated chronic obstructive pulmonary disease, require postoperative ventilatory and vasopressor support, and undergo amputation rather than salvage for acute leg ischemia. No statistically significant differences between pre-COVID and COVID cohorts were observed with gender, race, age, smoking, cardiac history or perioperative events, dialysis or preoperative creatinine, prior aneurysm repair, intervention choice of open versus endovascular aneurysm repair, maximum AAA diameter, or postoperative length of stay. CONCLUSIONS: The COVID-19 epidemic introduced numerous structural changes in health care, creating delays and obstacles to patients' abilities to receive prehospital and hospital care. Despite these systems-level obstacles with a highly morbid disease process, COVID era patients were not at an increased risk for mortality regardless of COVID status and were largely comparable to pre-COVID era patients.
引用
- Huang A, Henke P, Kasper G, et al. The Impact of the COVID-19 Public Health Crisis on the Surgical Management of Abdominal Aortic Aneurysm Rupture. Ann Vasc Surg. 2024. PMID: 39732327. doi:10.1016/j.avsg.2024.12.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。